Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)

Clinical trial NCT06952452 · RECRUITING

Trial details

NCT number: NCT06952452
Sponsor: Parc de Salut Mar
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Wet Age-related Macular Degeneration

Start date: 2022-11-18
Primary completion: 2026-07-01
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.